CA1296641C - Composition nutritionelle et physiologiquement active - Google Patents

Composition nutritionelle et physiologiquement active

Info

Publication number: CA1296641C
Authority: CA; Canada
Prior art keywords: derivatives; acid; weight; group; component
Prior art date: 1986-11-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

CA000552924A

Other languages

English (en)

Inventor

Shlomo Yehuda

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bar Ilan University

Original Assignee

Bar Ilan University

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-11-26

Filing date

1987-11-26

Publication date

1992-03-03

1986-11-26 Priority claimed from IL80786A external-priority patent/IL80786A/xx

1987-10-25 Priority claimed from IL84273A external-priority patent/IL84273A0/xx

1987-11-26 Application filed by Bar Ilan University filed Critical Bar Ilan University

1992-03-03 Application granted granted Critical

1992-03-03 Publication of CA1296641C publication Critical patent/CA1296641C/fr

2009-03-03 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

239000000203 mixture Substances 0.000 title claims abstract description 98
235000016709 nutrition Nutrition 0.000 title claims abstract description 49
239000002253 acid Substances 0.000 claims abstract description 65
OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims abstract description 37
DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims abstract description 33
150000001875 compounds Chemical class 0.000 claims abstract description 32
150000007513 acids Chemical class 0.000 claims abstract description 29
235000020661 alpha-linolenic acid Nutrition 0.000 claims abstract description 27
239000003085 diluting agent Substances 0.000 claims abstract description 25
239000008194 pharmaceutical composition Substances 0.000 claims abstract description 25
235000020778 linoleic acid Nutrition 0.000 claims abstract description 24
229960004488 linolenic acid Drugs 0.000 claims abstract description 22
KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 claims abstract description 22
OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims abstract description 20
206010012289 Dementia Diseases 0.000 claims abstract description 16
206010015037 epilepsy Diseases 0.000 claims abstract description 16
208000024891 symptom Diseases 0.000 claims abstract description 13
230000006993 memory improvement Effects 0.000 claims abstract description 10
230000001766 physiological effect Effects 0.000 claims abstract description 10
241000124008 Mammalia Species 0.000 claims abstract description 9
230000033228 biological regulation Effects 0.000 claims abstract description 9
230000005764 inhibitory process Effects 0.000 claims abstract description 9
230000007958 sleep Effects 0.000 claims abstract description 9
206010039966 Senile dementia Diseases 0.000 claims abstract description 8
230000036592 analgesia Effects 0.000 claims abstract description 8
WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims abstract description 6
LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims abstract description 6
QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims abstract description 6
ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims abstract description 6
239000005642 Oleic acid Substances 0.000 claims abstract description 6
QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims abstract description 6
ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims abstract description 6
150000004671 saturated fatty acids Chemical class 0.000 claims abstract description 5
235000003441 saturated fatty acids Nutrition 0.000 claims abstract description 5
239000004615 ingredient Substances 0.000 claims description 32
208000024827 Alzheimer disease Diseases 0.000 claims description 15
238000000034 method Methods 0.000 claims description 15
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 14
150000003839 salts Chemical class 0.000 claims description 14
229940088594 vitamin Drugs 0.000 claims description 12
229930003231 vitamin Natural products 0.000 claims description 12
235000013343 vitamin Nutrition 0.000 claims description 12
239000011782 vitamin Substances 0.000 claims description 12
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
150000001408 amides Chemical class 0.000 claims description 11
150000002148 esters Chemical class 0.000 claims description 11
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 10
FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 10
229940094443 oxytocics prostaglandins Drugs 0.000 claims description 10
150000003180 prostaglandins Chemical class 0.000 claims description 10
LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 10
235000021122 unsaturated fatty acids Nutrition 0.000 claims description 10
150000004670 unsaturated fatty acids Chemical class 0.000 claims description 10
GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 9
MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 claims description 8
230000001939 inductive effect Effects 0.000 claims description 8
235000013311 vegetables Nutrition 0.000 claims description 8
235000008504 concentrate Nutrition 0.000 claims description 7
GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 7
235000014113 dietary fatty acids Nutrition 0.000 claims description 7
229930195729 fatty acid Natural products 0.000 claims description 7
239000000194 fatty acid Substances 0.000 claims description 7
150000004665 fatty acids Chemical class 0.000 claims description 7
229910052742 iron Inorganic materials 0.000 claims description 7
239000000126 substance Substances 0.000 claims description 7
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 6
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 6
239000011574 phosphorus Substances 0.000 claims description 6
229910052698 phosphorus Inorganic materials 0.000 claims description 6
FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 5
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 5
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 5
VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 5
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 5
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 5
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 5
ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 5
BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 5
JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims description 5
MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 claims description 5
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 5
239000003963 antioxidant agent Substances 0.000 claims description 5
235000006708 antioxidants Nutrition 0.000 claims description 5
235000010323 ascorbic acid Nutrition 0.000 claims description 5
229960005070 ascorbic acid Drugs 0.000 claims description 5
239000011668 ascorbic acid Substances 0.000 claims description 5
239000011575 calcium Substances 0.000 claims description 5
229910052791 calcium Inorganic materials 0.000 claims description 5
239000000969 carrier Substances 0.000 claims description 5
239000000460 chlorine Substances 0.000 claims description 5
229910052801 chlorine Inorganic materials 0.000 claims description 5
229910052804 chromium Inorganic materials 0.000 claims description 5
239000011651 chromium Substances 0.000 claims description 5
229910017052 cobalt Inorganic materials 0.000 claims description 5
239000010941 cobalt Substances 0.000 claims description 5
GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims description 5
229910052802 copper Inorganic materials 0.000 claims description 5
239000010949 copper Substances 0.000 claims description 5
239000002270 dispersing agent Substances 0.000 claims description 5
229960002061 ergocalciferol Drugs 0.000 claims description 5
239000011737 fluorine Substances 0.000 claims description 5
229910052731 fluorine Inorganic materials 0.000 claims description 5
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 5
WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 5
229910052750 molybdenum Inorganic materials 0.000 claims description 5
239000011733 molybdenum Substances 0.000 claims description 5
239000011591 potassium Substances 0.000 claims description 5
229910052700 potassium Inorganic materials 0.000 claims description 5
235000008160 pyridoxine Nutrition 0.000 claims description 5
239000011677 pyridoxine Substances 0.000 claims description 5
229960003471 retinol Drugs 0.000 claims description 5
235000020944 retinol Nutrition 0.000 claims description 5
239000011607 retinol Substances 0.000 claims description 5
239000011669 selenium Substances 0.000 claims description 5
229910052711 selenium Inorganic materials 0.000 claims description 5
229910052708 sodium Inorganic materials 0.000 claims description 5
239000011734 sodium Substances 0.000 claims description 5
239000000375 suspending agent Substances 0.000 claims description 5
229960003495 thiamine Drugs 0.000 claims description 5
KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims description 5
235000019157 thiamine Nutrition 0.000 claims description 5
239000011721 thiamine Substances 0.000 claims description 5
229930003799 tocopherol Natural products 0.000 claims description 5
239000011732 tocopherol Substances 0.000 claims description 5
229960001295 tocopherol Drugs 0.000 claims description 5
235000010384 tocopherol Nutrition 0.000 claims description 5
MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 claims description 5
235000001892 vitamin D2 Nutrition 0.000 claims description 5
239000011653 vitamin D2 Substances 0.000 claims description 5
229940011671 vitamin b6 Drugs 0.000 claims description 5
239000011701 zinc Substances 0.000 claims description 5
229910052725 zinc Inorganic materials 0.000 claims description 5
235000013361 beverage Nutrition 0.000 claims description 4
239000002775 capsule Substances 0.000 claims description 4
235000013339 cereals Nutrition 0.000 claims description 4
235000009508 confectionery Nutrition 0.000 claims description 4
235000013399 edible fruits Nutrition 0.000 claims description 4
239000000243 solution Substances 0.000 claims description 4
239000006188 syrup Substances 0.000 claims description 4
235000020357 syrup Nutrition 0.000 claims description 4
235000012711 vitamin K3 Nutrition 0.000 claims description 4
239000011652 vitamin K3 Substances 0.000 claims description 4
229940041603 vitamin k 3 Drugs 0.000 claims description 4
239000012141 concentrate Substances 0.000 claims description 3
239000006185 dispersion Substances 0.000 claims description 3
239000000499 gel Substances 0.000 claims description 3
239000003701 inert diluent Substances 0.000 claims description 3
239000000546 pharmaceutical excipient Substances 0.000 claims description 3
239000000843 powder Substances 0.000 claims description 3
239000000725 suspension Substances 0.000 claims description 3
239000003826 tablet Substances 0.000 claims description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims 8
GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims 8
AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims 8
OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims 8
GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims 4
AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims 4
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 4
OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims 4
PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims 4
NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 4
229960002685 biotin Drugs 0.000 claims 4
235000020958 biotin Nutrition 0.000 claims 4
239000011616 biotin Substances 0.000 claims 4
ASARMUCNOOHMLO-WLORSUFZSA-L cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2s)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O ASARMUCNOOHMLO-WLORSUFZSA-L 0.000 claims 4
229960000304 folic acid Drugs 0.000 claims 4
235000019152 folic acid Nutrition 0.000 claims 4
239000011724 folic acid Substances 0.000 claims 4
239000011777 magnesium Substances 0.000 claims 4
229910052749 magnesium Inorganic materials 0.000 claims 4
229960003512 nicotinic acid Drugs 0.000 claims 4
235000001968 nicotinic acid Nutrition 0.000 claims 4
239000011664 nicotinic acid Substances 0.000 claims 4
229940055726 pantothenic acid Drugs 0.000 claims 4
235000019161 pantothenic acid Nutrition 0.000 claims 4
239000011713 pantothenic acid Substances 0.000 claims 4
229960002477 riboflavin Drugs 0.000 claims 4
235000019192 riboflavin Nutrition 0.000 claims 4
239000002151 riboflavin Substances 0.000 claims 4
239000011593 sulfur Substances 0.000 claims 4
229910052717 sulfur Inorganic materials 0.000 claims 4
235000020993 ground meat Nutrition 0.000 claims 2
201000010099 disease Diseases 0.000 abstract description 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
239000013589 supplement Substances 0.000 abstract 2
241000700159 Rattus Species 0.000 description 66
238000011282 treatment Methods 0.000 description 30
230000013016 learning Effects 0.000 description 20
CWRVKFFCRWGWCS-UHFFFAOYSA-N Pentrazole Chemical compound C1CCCCC2=NN=NN21 CWRVKFFCRWGWCS-UHFFFAOYSA-N 0.000 description 18
230000000694 effects Effects 0.000 description 18
239000003921 oil Substances 0.000 description 16
235000019198 oils Nutrition 0.000 description 16
206010010904 Convulsion Diseases 0.000 description 14
238000012360 testing method Methods 0.000 description 14
208000034308 Grand mal convulsion Diseases 0.000 description 11
235000005911 diet Nutrition 0.000 description 11
230000037213 diet Effects 0.000 description 11
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
230000009286 beneficial effect Effects 0.000 description 10
238000002347 injection Methods 0.000 description 10
239000007924 injection Substances 0.000 description 10
229960004232 linoleic acid Drugs 0.000 description 10
239000000902 placebo Substances 0.000 description 10
229940068196 placebo Drugs 0.000 description 10
238000002474 experimental method Methods 0.000 description 9
239000011780 sodium chloride Substances 0.000 description 8
241001465754 Metazoa Species 0.000 description 6
239000001195 (9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid Substances 0.000 description 5
230000036528 appetite Effects 0.000 description 5
235000019789 appetite Nutrition 0.000 description 5
230000002939 deleterious effect Effects 0.000 description 5
235000013305 food Nutrition 0.000 description 5
238000009472 formulation Methods 0.000 description 5
230000036651 mood Effects 0.000 description 5
208000004547 Hallucinations Diseases 0.000 description 4
241000282412 Homo Species 0.000 description 4
230000036626 alertness Effects 0.000 description 4
-1 amine salts Chemical class 0.000 description 4
150000001412 amines Chemical class 0.000 description 4
238000010171 animal model Methods 0.000 description 4
239000008280 blood Substances 0.000 description 4
210000004369 blood Anatomy 0.000 description 4
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
229940079593 drug Drugs 0.000 description 4
239000003814 drug Substances 0.000 description 4
150000002500 ions Chemical class 0.000 description 4
125000005481 linolenic acid group Chemical group 0.000 description 4
230000003340 mental effect Effects 0.000 description 4
230000037023 motor activity Effects 0.000 description 4
IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 description 4
229920006395 saturated elastomer Polymers 0.000 description 4
208000019116 sleep disease Diseases 0.000 description 4
KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 3
238000010306 acid treatment Methods 0.000 description 3
230000002411 adverse Effects 0.000 description 3
210000004556 brain Anatomy 0.000 description 3
230000000112 colonic effect Effects 0.000 description 3
235000005687 corn oil Nutrition 0.000 description 3
230000007787 long-term memory Effects 0.000 description 3
230000006371 metabolic abnormality Effects 0.000 description 3
230000006403 short-term memory Effects 0.000 description 3
241000894007 species Species 0.000 description 3
239000003981 vehicle Substances 0.000 description 3
206010011906 Death Diseases 0.000 description 2
229910015400 FeC13 Inorganic materials 0.000 description 2
208000002193 Pain Diseases 0.000 description 2
208000000114 Pain Threshold Diseases 0.000 description 2
235000019486 Sunflower oil Nutrition 0.000 description 2
244000299461 Theobroma cacao Species 0.000 description 2
230000002159 abnormal effect Effects 0.000 description 2
229940087168 alpha tocopherol Drugs 0.000 description 2
YVPYQUNUQOZFHG-UHFFFAOYSA-N amidotrizoic acid Chemical compound CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I YVPYQUNUQOZFHG-UHFFFAOYSA-N 0.000 description 2
239000001961 anticonvulsive agent Substances 0.000 description 2
235000021342 arachidonic acid Nutrition 0.000 description 2
230000006399 behavior Effects 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
230000036772 blood pressure Effects 0.000 description 2
230000008859 change Effects 0.000 description 2
230000000052 comparative effect Effects 0.000 description 2
239000002285 corn oil Substances 0.000 description 2
230000000875 corresponding effect Effects 0.000 description 2
230000034994 death Effects 0.000 description 2
231100000517 death Toxicity 0.000 description 2
230000006735 deficit Effects 0.000 description 2
229960000632 dexamfetamine Drugs 0.000 description 2
235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
230000001747 exhibiting effect Effects 0.000 description 2
230000037406 food intake Effects 0.000 description 2
235000012631 food intake Nutrition 0.000 description 2
150000002391 heterocyclic compounds Chemical class 0.000 description 2
IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
229910052500 inorganic mineral Inorganic materials 0.000 description 2
230000002045 lasting effect Effects 0.000 description 2
239000000944 linseed oil Substances 0.000 description 2
235000021388 linseed oil Nutrition 0.000 description 2
230000033001 locomotion Effects 0.000 description 2
239000000463 material Substances 0.000 description 2
235000012054 meals Nutrition 0.000 description 2
230000015654 memory Effects 0.000 description 2
239000011707 mineral Substances 0.000 description 2
239000004006 olive oil Substances 0.000 description 2
235000008390 olive oil Nutrition 0.000 description 2
230000008520 organization Effects 0.000 description 2
230000036407 pain Effects 0.000 description 2
230000037040 pain threshold Effects 0.000 description 2
230000000384 rearing effect Effects 0.000 description 2
208000022925 sleep disturbance Diseases 0.000 description 2
235000012424 soybean oil Nutrition 0.000 description 2
239000002600 sunflower oil Substances 0.000 description 2
229960000984 tocofersolan Drugs 0.000 description 2
210000001364 upper extremity Anatomy 0.000 description 2
210000002700 urine Anatomy 0.000 description 2
150000003722 vitamin derivatives Chemical class 0.000 description 2
235000004835 α-tocopherol Nutrition 0.000 description 2
239000002076 α-tocopherol Substances 0.000 description 2
BHMLFPOTZYRDKA-IRXDYDNUSA-N (2s)-2-[(s)-(2-iodophenoxy)-phenylmethyl]morpholine Chemical compound IC1=CC=CC=C1O[C@@H](C=1C=CC=CC=1)[C@H]1OCCNC1 BHMLFPOTZYRDKA-IRXDYDNUSA-N 0.000 description 1
OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
MBEVSMZJMIQVBG-UHFFFAOYSA-N 2-(hydroxymethyl)guanidine Chemical compound NC(N)=NCO MBEVSMZJMIQVBG-UHFFFAOYSA-N 0.000 description 1
208000021959 Abnormal metabolism Diseases 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
244000144725 Amygdalus communis Species 0.000 description 1
235000011437 Amygdalus communis Nutrition 0.000 description 1
241001535291 Analges Species 0.000 description 1
235000019737 Animal fat Nutrition 0.000 description 1
235000005979 Citrus limon Nutrition 0.000 description 1
244000131522 Citrus pyriformis Species 0.000 description 1
206010012735 Diarrhoea Diseases 0.000 description 1
235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 description 1
206010052804 Drug tolerance Diseases 0.000 description 1
101150039033 Eci2 gene Proteins 0.000 description 1
208000017701 Endocrine disease Diseases 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
AIKKULXCBHRFOS-UHFFFAOYSA-N Formothion Chemical compound COP(=S)(OC)SCC(=O)N(C)C=O AIKKULXCBHRFOS-UHFFFAOYSA-N 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
206010019070 Hallucination, auditory Diseases 0.000 description 1
206010019075 Hallucination, visual Diseases 0.000 description 1
101000996834 Homo sapiens Linker for activation of T-cells family member 2 Proteins 0.000 description 1
206010021750 Infantile Spasms Diseases 0.000 description 1
206010061216 Infarction Diseases 0.000 description 1
206010022971 Iron Deficiencies Diseases 0.000 description 1
AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
102100034238 Linker for activation of T-cells family member 2 Human genes 0.000 description 1
208000007101 Muscle Cramp Diseases 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
GMZVRMREEHBGGF-UHFFFAOYSA-N Piracetam Chemical compound NC(=O)CN1CCCC1=O GMZVRMREEHBGGF-UHFFFAOYSA-N 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
241001296096 Probles Species 0.000 description 1
208000028017 Psychotic disease Diseases 0.000 description 1
244000191761 Sida cordifolia Species 0.000 description 1
208000005392 Spasm Diseases 0.000 description 1
235000021355 Stearic acid Nutrition 0.000 description 1
229910000831 Steel Inorganic materials 0.000 description 1
235000009470 Theobroma cacao Nutrition 0.000 description 1
229930003427 Vitamin E Natural products 0.000 description 1
201000006791 West syndrome Diseases 0.000 description 1
240000008042 Zea mays Species 0.000 description 1
206010000059 abdominal discomfort Diseases 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
230000032683 aging Effects 0.000 description 1
235000020224 almond Nutrition 0.000 description 1
229940025084 amphetamine Drugs 0.000 description 1
210000004727 amygdala Anatomy 0.000 description 1
238000000540 analysis of variance Methods 0.000 description 1
230000003556 anti-epileptic effect Effects 0.000 description 1
230000003078 antioxidant effect Effects 0.000 description 1
230000002567 autonomic effect Effects 0.000 description 1
229940125717 barbiturate Drugs 0.000 description 1
229940049706 benzodiazepine Drugs 0.000 description 1
125000003310 benzodiazepinyl group Chemical class N1N=C(C=CC2=C1C=CC=C2)* 0.000 description 1
238000012742 biochemical analysis Methods 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
230000008033 biological extinction Effects 0.000 description 1
230000037396 body weight Effects 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
150000001735 carboxylic acids Chemical class 0.000 description 1
208000015114 central nervous system disease Diseases 0.000 description 1
235000019219 chocolate Nutrition 0.000 description 1
235000012000 cholesterol Nutrition 0.000 description 1
229940127243 cholinergic drug Drugs 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
230000007278 cognition impairment Effects 0.000 description 1
230000008602 contraction Effects 0.000 description 1
239000003179 convulsant agent Substances 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
235000012343 cottonseed oil Nutrition 0.000 description 1
239000013078 crystal Substances 0.000 description 1
230000002950 deficient Effects 0.000 description 1
230000003001 depressive effect Effects 0.000 description 1
NIJJYAXOARWZEE-UHFFFAOYSA-N di-n-propyl-acetic acid Natural products CCCC(C(O)=O)CCC NIJJYAXOARWZEE-UHFFFAOYSA-N 0.000 description 1
230000003205 diastolic effect Effects 0.000 description 1
150000007655 dibenzoazepines Chemical class 0.000 description 1
230000003292 diminished effect Effects 0.000 description 1
239000000839 emulsion Substances 0.000 description 1
238000005538 encapsulation Methods 0.000 description 1
208000030172 endocrine system disease Diseases 0.000 description 1
230000001037 epileptic effect Effects 0.000 description 1
208000028329 epileptic seizure Diseases 0.000 description 1
230000002397 epileptogenic effect Effects 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
210000003414 extremity Anatomy 0.000 description 1
235000020664 gamma-linolenic acid Nutrition 0.000 description 1
WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
230000014509 gene expression Effects 0.000 description 1
125000005456 glyceride group Chemical group 0.000 description 1
230000036449 good health Effects 0.000 description 1
239000008187 granular material Substances 0.000 description 1
230000026781 habituation Effects 0.000 description 1
125000000623 heterocyclic group Chemical class 0.000 description 1
229940088597 hormone Drugs 0.000 description 1
239000005556 hormone Substances 0.000 description 1
208000003906 hydrocephalus Diseases 0.000 description 1
230000003301 hydrolyzing effect Effects 0.000 description 1
230000002631 hypothermal effect Effects 0.000 description 1
238000002513 implantation Methods 0.000 description 1
230000006872 improvement Effects 0.000 description 1
230000007574 infarction Effects 0.000 description 1
238000011835 investigation Methods 0.000 description 1
238000009533 lab test Methods 0.000 description 1
235000015122 lemonade Nutrition 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
230000007774 longterm Effects 0.000 description 1
210000003141 lower extremity Anatomy 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
230000027939 micturition Effects 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
235000003170 nutritional factors Nutrition 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
229940126701 oral medication Drugs 0.000 description 1
239000013610 patient sample Substances 0.000 description 1
230000000144 pharmacologic effect Effects 0.000 description 1
HCTVWSOKIJULET-LQDWTQKMSA-M phenoxymethylpenicillin potassium Chemical compound [K+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)COC1=CC=CC=C1 HCTVWSOKIJULET-LQDWTQKMSA-M 0.000 description 1
229960004526 piracetam Drugs 0.000 description 1
229920001223 polyethylene glycol Polymers 0.000 description 1
230000008092 positive effect Effects 0.000 description 1
235000008476 powdered milk Nutrition 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
230000003236 psychic effect Effects 0.000 description 1
230000011514 reflex Effects 0.000 description 1
230000010076 replication Effects 0.000 description 1
230000004044 response Effects 0.000 description 1
210000003296 saliva Anatomy 0.000 description 1
230000001953 sensory effect Effects 0.000 description 1
210000002460 smooth muscle Anatomy 0.000 description 1
GFWRVVCDTLRWPK-KPKJPENVSA-N sofalcone Chemical compound C1=CC(OCC=C(C)C)=CC=C1\C=C\C(=O)C1=CC=C(OCC=C(C)C)C=C1OCC(O)=O GFWRVVCDTLRWPK-KPKJPENVSA-N 0.000 description 1
239000003549 soybean oil Substances 0.000 description 1
239000008117 stearic acid Substances 0.000 description 1
239000010959 steel Substances 0.000 description 1
239000000021 stimulant Substances 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
BGRJTUBHPOOWDU-UHFFFAOYSA-N sulpiride Chemical compound CCN1CCCC1CNC(=O)C1=CC(S(N)(=O)=O)=CC=C1OC BGRJTUBHPOOWDU-UHFFFAOYSA-N 0.000 description 1
239000002511 suppository base Substances 0.000 description 1
230000009182 swimming Effects 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
230000028016 temperature homeostasis Effects 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
238000012549 training Methods 0.000 description 1
MSRILKIQRXUYCT-UHFFFAOYSA-M valproate semisodium Chemical compound [Na+].CCCC(C(O)=O)CCC.CCCC(C([O-])=O)CCC MSRILKIQRXUYCT-UHFFFAOYSA-M 0.000 description 1
229960000604 valproic acid Drugs 0.000 description 1
235000015112 vegetable and seed oil Nutrition 0.000 description 1
239000008158 vegetable oil Substances 0.000 description 1
235000019165 vitamin E Nutrition 0.000 description 1
239000011709 vitamin E Substances 0.000 description 1
229940046009 vitamin E Drugs 0.000 description 1
238000005303 weighing Methods 0.000 description 1
235000019786 weight gain Nutrition 0.000 description 1

Landscapes

Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

CA000552924A 1986-11-26 1987-11-26 Composition nutritionelle et physiologiquement active Expired - Lifetime CA1296641C (fr)

Applications Claiming Priority (8)

Application Number	Priority Date	Filing Date	Title
IL80786A IL80786A (en)	1986-11-26	1986-11-26	Physiologically active and nutritional composition containing a mixture of linolenic and linoleic acids
IL80786		1987-10-25
IL84273		1987-10-25
IL84273A IL84273A0 (en)	1987-10-25	1987-10-25	Physiologically active and nutritional composition
US26354088A	1988-10-27	1988-10-27
IL263,548		1988-10-27
US35956289A	1989-06-01	1989-06-01
IL07/359,562		1989-06-01

Publications (1)

Publication Number	Publication Date
CA1296641C true CA1296641C (fr)	1992-03-03

Family

ID=27452289

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000552924A Expired - Lifetime CA1296641C (fr)	1986-11-26	1987-11-26	Composition nutritionelle et physiologiquement active

Country Status (1)

Country	Link
CA (1)	CA1296641C (fr)

1987
- 1987-11-26 CA CA000552924A patent/CA1296641C/fr not_active Expired - Lifetime

Legal Events

Date	Code	Title	Description
2009-03-03	MKLA	Lapsed
2012-12-05	MKEC	Expiry (correction)	Effective date: 20121205

Publication	Publication Date	Title
US4851431A (en)	1989-07-25	Physiologically active and nutritional composition
CA2186673C (fr)	2008-07-22	Utilisation d'acides gras dans le traitement de la choree de huntington
JP7414083B2 (ja)	2024-01-16	認知症またはうつ状態の予防または改善用組成物
EP0366480B1 (fr)	1994-08-24	Méthode et compositions de traitement de la maladie d'Alzheimer, de démences apparentées et de l'épilepsie
AU2218797A (en)	1998-01-05	Method for maintaining an existing level of body fat and/or body weight
Kölmel	1991	Peduncular hallucinations
CA2698535A1 (fr)	2009-03-26	Formulations de supplements nutritifs a inclure dans les aliments, et aliments enrichis les comportant
HK1007110B (en)	1999-04-01	Method and compositions for treating alzheimer's disease, related dementias & epilepsy
US5468776A (en)	1995-11-21	Physiologically active and nutritional composition
KR100256452B1 (ko)	2000-05-15	뇌 활성화 제약학적 조성물 및 그 제조방법
AU2006266751A1 (en)	2007-01-11	Compositions for ameliorating a reduced higher brain function resulting from organic brain lesions
RU2009121007A (ru)	2010-12-10	Жирные спирты
JPH08283154A (ja)	1996-10-29	脂質代謝改善剤
US5120763A (en)	1992-06-09	Physiologically active and nutritional composition
US5599840A (en)	1997-02-04	Physiologically active and nutritional composition
WO2007119588A1 (fr)	2007-10-25	Agent ameliorant les fonctions cerebrales et aliment fonctionnel contenant l'agent ameliorant
EP0391218B1 (fr)	1996-03-13	Produit prophylactique pour l'atopie
JP3778509B2 (ja)	2006-05-24	眼の調節機能障害改善剤
AU709698B2 (en)	1999-09-02	Preventive or alleviating agent for medical symptoms caused by delayed allergy reactions
JP2004115429A (ja)	2004-04-15	視力向上剤
GB2700322A (en)	2026-01-21	Composition and use thereof
JP2004067537A (ja)	2004-03-04	交感神経の興奮抑制剤
AU2021257176A1 (en)	2022-11-10	Sleep quality improver
BR102020009112A2 (pt)	2021-11-16	Formulação de neuroprotetor
Misner	0	Fish Oil's Benefits Defended